阿斯利康 AZN 深沪

已收盘 08-07 16:00:00 美东时间

161.42

+1.410

+0.88%

华盛通

立即下载

最高162.18
今开162.14
成交量 372.04万股
最低 160.00
昨收 160.01
总市值 2503.43亿
52周最高 210.54
市盈率 ^静 24.66
换手率 0.24%
52周最低 143.62
委比 -48.51%
总股本 15.51亿
历史最高 210.54
量比 0.53
振幅 1.36%
历史最低 -25.0488
每手 1
风险率 15.22%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

SA Asks: What's the outlook for Big Pharma M&A?

Big Pharma moved back into the spotlight last week following a Financial Times report that Bristol Myers Squibb (BMY) was in merger talks with AstraZeneca (AZN), a development that was later denied by...

今天 03:28
Medical devices ETF nears breakout; here are its top holdings

The U.S. Medical Devices ETF (IHI) could be nearing a technical breakout as strength in the broader healthcare sector prompts investors to rotate into lagging industry groups, according to Donovan Jac...

08-07 23:07
GLP-1为王、专利悬崖逼近、新赛道抢跑：跨国药企2026上半年业绩背后的版图重组

每经记者｜陈星每经编辑｜李雨冰近日，全球制药巨头相继交出上半...

08-07 21:46
赛诺菲(SNY.US)长效RSV单抗新适应症申报上市

8月7日，CDE官网公示，赛诺菲(SNY.US)尼塞韦单抗注射液一项新适应症上市申请获得受理，注册分类为3.1类。根据公开信息和临床试验进展，Insight数据...

08-07 15:38
外企头条 | 4000亿美元！美英两大国际巨头洽谈合并

（来源：经济日报）转自：经济日报据英国媒体报道，英国阿斯利康与美国百时美施贵宝正就合并事宜展开谈判。一旦落地，将诞生一家市值近4000亿美元的制药巨头，跻身...

08-07 15:25
阿斯利康或将打破药企十年并购策略，大手笔收购换取美国市场规模

　　核心要点　　有报道称两大药企巨头洽谈合并。依托百时美施贵宝深耕美国的业务，阿斯利康可一举获得美国市场规模，但代价是增长放缓，并承担巨大整合风险。　　相关...

08-06 18:24
【百强透视】石药集团（01093.HK）再获跨国药企加持，价值重估在即？

8月6日，石药集团（01093.HK）高开震荡，截至收盘，公司股价涨1.49%，报8.5港元，市值979.41亿港元。 8月5日晚间公司发布重磅合作公告，宣布与...

08-06 16:23
从“卖产品”到“共建工厂”：石药与阿斯利康合资背后的产业范式跃迁

（来源：求实药社） 2026年8月5日，石药集团与阿斯利康正式签署合资合同，在石家庄共建新一代生物制剂生产基地。根据协议，石药集团持股51%，阿斯利康持股49...

08-06 12:10
Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update

Corbus Pharmaceuticals reported progress in its oncology and obesity pipeline, obtaining FDA clearance for the registrational study of CRB-701 in oropharyngeal cancer and completing the last patient visit in the CANYON-1 trial of CRB-913 for obesity. The company also appointed new leadership to strengthen its team. Financially, Corbus reported a net loss of $35 million for the second quarter, with $117.9 million in cash on hand.

08-06 12:00
一场千亿豪赌来了

（来源：东四十条资本）一家曾差点被同行吞下的公司，十二年后坐到了全球医药行业最大一张牌桌的主位。近日，英国《金融时报》爆料称，阿斯利康与百时美施贵宝正...

08-06 10:21

派息除权日	每股总股息	派息日期
2026-08-07	1.06	2026-09-08
2026-02-20	2.17	2026-03-23
2026-02-19	2.17	2026-03-23
2025-08-08	0.50	2025-09-08
2025-02-21	1.03	2025-03-24
2024-08-09	0.49	2024-09-09
2024-02-22	0.96	2024-03-25
2023-08-10	0.46	2023-09-11
2023-02-23	0.96	2023-03-27
2022-08-11	0.46	2022-09-12
2022-02-24	0.96	2022-03-28
2021-08-12	0.44	2021-09-13
2021-02-25	0.93	2021-03-29
2020-08-13	0.44	2020-09-14
2020-02-27	0.93	2020-03-30
2019-08-08	0.44	2019-09-09
2019-02-28	0.93	2019-03-27
2018-08-09	0.44	2018-09-10
2018-02-15	0.93	2018-03-19
2017-08-09	0.44	2017-09-11
2017-02-15	0.93	2017-03-20
2016-08-10	0.44	2016-09-12
2016-02-17	0.93	2016-03-21
2015-08-12	0.44	2015-09-14
2015-02-18	1.88	2015-03-23
2014-08-13	0.90	2014-09-15
2014-02-19	1.90	2014-03-24
2013-08-14	0.90	2013-09-16
2013-02-13	1.90	2013-03-18
2012-08-08	0.90	2012-09-10
2012-02-15	1.95	2012-03-19
2011-08-04	0.85	2011-09-12
2011-02-02	1.85	2011-03-14
2010-08-04	0.70	2010-09-13
2010-02-03	1.71	2010-03-15
2009-08-05	0.59	2009-09-14
2009-02-04	1.50	2009-03-16
2008-08-06	0.55	2008-09-15
2008-02-07	1.35	2008-03-17
2007-08-08	0.52	2007-09-17
2007-02-07	1.23	2007-03-19
2006-08-09	0.49	2006-09-18
2006-02-08	0.92	2006-03-20
2005-08-10	0.38	2005-09-19
2005-02-09	0.64	2005-03-21
2004-08-11	0.29	2004-09-20
2004-02-18	0.54	2004-04-06
2003-08-20	0.25	2003-10-06
2003-02-19	0.47	2003-04-07
2002-08-21	0.23	2002-10-07
2002-02-20	0.47	2002-04-08
2001-08-22	0.23	2001-10-05
2001-02-21	0.47	2001-04-09
2000-09-06	0.23	2000-10-23
2000-03-08	0.47	2000-04-17
1999-09-08	0.23	1999-10-25
1999-04-07	0.45	1999-04-28
1998-09-16	0.25	1998-11-09
1998-03-18	1.31	1998-05-12
1997-09-17	0.72	1997-11-10
1997-03-19	1.16	1997-05-13
1996-09-20	0.65	1996-11-14
1996-03-22	0.95	1996-05-14
1995-09-22	0.57	1995-11-13
1995-03-24	0.90	1995-05-16
1994-09-23	0.55	1994-11-14
1994-03-18	0.81	1994-05-12
1993-09-24	0.50	1993-11-16

公司名称	阿斯利康
行业分类	制药
业务描述	AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

阿斯利康 AZN 深 沪

161.42

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

阿斯利康 AZN 深沪